Suchergebnisse - "Lamivudine"

PubPharm (12.725)

1

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus : DUALING Prospective Nationwide Matched Cohort Study

enthalten in: Open forum infectious diseases | 2024

von Vasylyev, M. | Wit, F. | Jordans, C. | +23

2

Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed

enthalten in: Open forum infectious diseases | 2024

von Borghetti, A. | Ciccullo, A. | Lombardi, F. | +9

3

D3/Penta 21 clinical trial design : A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years

enthalten in: Contemporary clinical trials | 2024

von Turkova, A. | Chan, M. | Kityo, C. | +30

4

High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana

enthalten in: Viruses | 2024

von Phinius, B. | Anderson, M. | Gobe, I. | +11

5

Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Chandasana, H. | Singh, R. | Adkison, K. | +2

6

Impact of lamivudine treatment in late pregnancy on the development of the foetal immune response to hepatitis B virus : a meta-analysis in R with the metafor package

enthalten in: Transactions of the Royal Society of Tropical Medicine and Hygiene | 2024

von Zhao, P. | Zhao, Y. | Du, M. | +2

7

Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI) : a phase 3, open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2024

von Kankasa, C. | Mennecier, A. | Sakana, B. | +15

8

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings : Results from the TANDEM Study

enthalten in: Infectious diseases and therapy | 2024

von Schneider, S. | Blick, G. | Burke, C. | +13

9

Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads : TANDEM Study Subgroup Analyses

enthalten in: Infectious diseases and therapy | 2024

von Benson, P. | Kuretski, J. | Donovan, C. | +8

10

Effectiveness, Weight Changes, and Metabolic Outcomes on Switch to Generic Dolutegravir/Lamivudine Among People with HIV in Western India : An Observational Study

enthalten in: AIDS research and human retroviruses | 2024

von Pujari, S. | Gaikwad, S. | Panchawagh, S. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1273]